Daniel J. Starks - Jul 26, 2022 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role
Director
Signature
/s/ Daniel J. Starks by Jessica H. Paik, Attorney-in-Fact
Stock symbol
ABT
Transactions as of
Jul 26, 2022
Transactions value $
-$5,456,994
Form type
4
Date filed
7/28/2022, 05:20 PM
Previous filing
May 5, 2022
Next filing
Oct 31, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABT Common shares without par value Sale -$3.02M -27.7K -0.4% $108.77 6.95M Jul 26, 2022 Direct F1
transaction ABT Common shares without par value Sale -$2.44M -22.3K -0.32% $109.60 6.92M Jul 26, 2022 Direct F2
holding ABT Common shares without par value 258 Jul 26, 2022 Alynne Starks 2012 Irrevocable Trust F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.32 to $109.31, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.33 to $109.85 inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3 Held in the Alynne Starks 2012 Irrevocable Trust. The reporting person is the sole trustee of the trust.

Remarks:

These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).